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The effects of nitric oxide ('NO) and nitrovasodilators on the oxidation of low-density lipoprotein (LDL) have been studied. S-Nitroso-N- 
acetylpenicillamine (SNAP) and sodium nitroprusside (SNP) inhibited Cu 2÷- and 2,2'-azobis-2-amidinopropane hydrochloride-dependent oxidation 
of LDL as monitored by oxygen consumption and the formation of thiobarbituric acid-reactive substances, conjugated ienes, and lipid hydro- 
peroxides. In the case of SNP, inhibition of LDL oxidation occurred only when the incubation mixture was irradiated with visible light. SNAP, 
however, exerted a dose-dependent i hibition of CuZ÷-catalyzed oxidation of LDL even in the dark. Addition of "NO dissolved in deoxygenated 
buffer also inhibited the progression of LDL oxidation. Mouse peritoneal macrophages were less able to degrade LDL that had been oxidized in 
the presence of SNAR Using an "NO electrode, it was estimated that a continuous production of 'NO (~< 760 nM/min) could retard the progression 
of LDL oxidation. We propose that "NO can inhibit LDL oxidation by acting as a chain-breaking antioxidant that is capable of scavenging 
carbon-centered and peroxyl radicals. Biological implications of this novel °NO antioxidant property are discussed in relation to atherogenesis and 
contrasted to the prooxidant property of "NO when generated in the presence of superoxide. 
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1. INTRODUCTION 
The oxidation of low-density lipoprotein (LDL) has 
been implicated in the early stages of atherosclerotic 
lesion formation [1-3]. The hypothesis requires that 
LDL, which is trapped within the arterial wall, under- 
goes oxidation resulting in the recruitment of macro- 
phages to the intima. These macrophages then ingest 
the oxidized lipoprotein via macrophage scavenger re- 
ceptors [4]. Cholesterol accumulation is not regulated 
by macrophage-cholesterol levels; therefore, the cells 
become engorged with cholesterol-ester forming the 
'foam cells' observed in early atherosclerotic lesions [5]. 
While the in vivo mechanism of LDL oxidation re- 
mains unclear, several in vitro systems, e.g. Cu 2+, azo- 
initiators, lipoxygenases, macrophages, endothelial and 
smooth muscle cells, have been shown to oxidize LDL 
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Abbreviations: ABAP, 2,2'-azobis(2-amidinopropane hydrochloride); 
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oxyl radicals; LOOH, lipid hydroperoxide; MDA, malondialdehyde; 
°NO, nitric oxide; -OONO, peroxynitrite; PBS, phosphate-buffered 
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prusside; TBA, thiobarbituric acid; TBARS, thiobarbituric acid-reac- 
tive substances. 
[3,6]. Recently, there has been much interest in the role 
of nitric oxide ('NO) in atherosclerosis because of the 
discovery that many of the cell types associated with 
atherosclerotic lesions produce "NO [7]. It has also been 
demonstrated that "NO-dependent vasodilation is in- 
hibited by oxidized LDL [8]. 
"NO has been reported to have a dual effect on LDL 
oxidation. In macrophage-dependent oxidation of 
LDL, increased "NO production has been shown to be 
protective [9,10]; whereas, in systems containing LDL 
and superoxide, "NO exhibits prooxidant behavior. The 
simultaneous release of "NO and superoxide has been 
shown to modify LDL to an oxidized and potentially 
atherogenic form [11,12]. It has been postulated that the 
prooxidant effect of "NO in the presence of superoxide 
occurs through the formation of peroxynitrite 
(-OONO) [13-15]. However, the mechanism by which 
cytokine-stimulation f "NO inhibits the macrophage- 
dependent oxidative modification of LDL is poorly un- 
derstood. Clearly, the reaction between "NO and super- 
oxide cannot account for the protective mechanism of 
"NO, as the resulting -OONO is a more potent oxidant 
than either superoxide or "NO alone [12]. Recently, it 
has been suggested that either chelation of redox-active 
metal ions by "NO, formation of nitrosothiols, or reac- 
tion between "NO and intracellular i on- containing en- 
zymes such as lipoxygenase could account for this pro- 
tection [9,16]. 
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In this communication, we show that a continuous 
generation of "NO can totally inhibit LDL oxidation 
and propose a novel antioxidant mechanism of action 
for "NO. We have used sodium nitroprusside (SNP)/ 
light, S-nitroso-N-acetylpeniciUamine (SNAP) and au- 
thentic "NO solution during the oxidation of LDL by 
Cu 2+, and 2,2"-azobis(2-amidinopropane hydrochlo- 
ride) (ABAP). We show that, under these conditions, 
"NO acts only as an antioxidant. 
2. MATERIALS AND METHODS 
2.1. Materials 
SNP, copper (II) sulfate, and butylatedhydroxytoluene were pur- 
chased from Sigma Chemical Co. (St. Louis, MO). ABAP was ob- 
tained from Polyscience, Inc. (Worrington, PA). SNAP was synthe- 
sized from N-acetyl-D,L-penicillamine as described by Field et al. [17]. 
Stock solutions of SNAP were prepared in 50 mM H2SO4. Solutions 
of "NO were prepared from NO gas (99% purity) obtained from 
Matheson Gas Co. (Madison, WI). NO was bubbled through a satu- 
rated solution of NaOH before addition to a sealed vessel containing 
deionized water. The vessel had previously been evacuated to remove 
other gasses from solution. Human LDL was isolated from plasma s 
described previously [18]. Resident peritoneal macrophages were ob- 
tained from female Swiss-Webster mice as described previously [19]. 
2.2. LDL oxidation 
LDL (100/2g protein/ml) was incubated with either Cu 2+ (10/IM) 
or ABAP (1 mM) alone or in the presence of SNP, SNAP, or "NO. 
All incubations were performed in Dulbecco's phosphate-buffered sa- 
line (PBS) at 37°C in open vessels that were continually stirred. Ali- 
quots were removed at the indicated time points for measurement of
thiobarbituric acid-reactive substances (TBARS) or lipid hydroperox- 
ide (LOOH). Irradiation was performed using a Viewlex projector 
through a clear glass window in the side of the incubator chamber. 
2.3. TBARS measurement 
LDL (10 20/lg) was incubated with thiobarbituric acid (TBA, 0.5% 
w/v) in H2SO4 (50 raM) for 30 min in a boiling water bath and then 
centrifuged at 2000 rpm. TBARS concentrations were calculated as 
malondialdehyde (MDA) equivalents using the extinction coefficient 
of 150 mM -~ .cm -1 at 532 nm. 
2.4. Conjugated iene formation 
Oxidation of LDL (100 ,ug/ml) was monitored continuously at 234 
nm [20]. Oxidation was initiated by the addition of Cu 2+ (5/~M) to the 
sample cuvette. 
2.5. Iodometric measurement 
Total LOOH were determined by a microiodometric method ac- 
cording to Girotti et aI. [21] with minor variations. Quantitation was 
based on an absorption coefficient of 22.5 mM -~. cm -I, as determined 
with enzymaticalty standardized t-butyl hydroperoxide. 
2.6. "NO measurement 
"NO was measured using a commercially available "NO meter (Iso- 
NO, World Precision Instruments, Inc., Sarasota, FL). The electrode 
was calibrated by the method outlined in the product literature (see 
[22]), 
2.7. Macrophage degradation of LDL 
The uptake and degradation of [~25I]LDL by mouse peritoneal mac- 
rophages was measured as the appearance of trichloroacetic acid- 
soluble radioactivity. This non-iodide radioactivity was formed by 
cells and excreted in the medium following a 5 h incubation of oxidized 
[IzSI]LDL with the cells [19]. 
3. RESULTS 
3.1. Effects of SNP/light on Cu2+-catalyzed oxidation of 
LDL 
SNP releases "NO when exposed to visible light 
[23,24]. Incubation of LDL and Cu z+ at 37°C in PBS 
resulted in the generation ofboth TBARS (Fig. 1A) and 
LOOH (Fig. 1B). The largest change in both parameters 
was observed uring the first hour of incubation. This 
corresponds well with previous reports of Cu2+-depend - 
ent oxidation of LDL if it is assumed that the lag-period 
of the oxidation process is complete within the first hour 
[3]. In the presence of SNP where light was strictly 
excluded from the reaction vessel, a slight inhibition of 
the generation of both TBARS (Fig. 1A) and LOOH 
(Fig. 1B) was observed. However, after a 4-h incuba- 
tion, levels of both oxidation products were similar to 
control evels. When the incubation mixture was irradi- 
ated continuously, a dramatic inhibition of LDL oxida- 
tion was observed (Fig. 1A and 1B). This suggests that 
"NO released from SNP during irradiation is responsi- 
ble for the observed inhibition. 
3.2. Effects of SNAP on Cu2+-catalyzed LDL oxidation 
SNAP has been shown to produce "NO spontane- 
ously at physiological pH [17]. Fig. 2A shows the effect 
of SNAP on the formation of conjugated dienes during 
Cu2+-catalyzed oxidation of LDL. Cu2+-dependent oxi- 
dation of LDL exhibits characteristic kinetics as shown 
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Fig. 1. Effects of SNP on Cu2+-catalyzed oxidation of LDL. LDL (100 
Hg/ml) was incubated with Cu 2÷ (10 HM) at 37°C in PBS. Experiments 
were performed in the absence of SNP (m), in the presence of SNP (100 
JIM) in the dark (~x) and in the presence of SNP (100 HM) and light 
(e). All experiments were performed in duplicate using the same prep- 
aration of LDL. Oxidation was measured by the formation of both 
(A) TBARS and (B) LOOH. Data points represent means of duplicate 
measurements. The average rror was approximately _+l nmol/mg for 
TBARS and + 100 nmol/mg for LOOH. 
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in Fig. 2A (trace 1). The time course consists of a slow 
rate of oxidation (the lag period) followed by a rapid 
rise in the rate of formation of conjugated ienes [20]. 
As shown in Fig. 2A, SNAP increased the length of the 
lag-period of LDL oxidation in a concentration-de- 
pendent manner. In the presence of 2.5 mM SNAP, 
there were no detectable increases in the levels of conju- 
gated dienes for up to 10 h. However, after 24 h, this 
sample also had a greater amount of conjugated iene 
formation (data not shown) suggesting oxidation had 
occurred. The length of the lag-period lay between 10 
and 24 h. As with conjugated iene formation, SNAP 
addition also results in an increase in the length of the 
lag-period of oxidation as measured by TBARS forma- 
tion (Fig. 2B). Consistent with these results, CuZ+-cata - 
lyzed oxidation of LDL in the presence of SNAP (1 
mM) exhibited a lower propensity toward macrophage 
degradation (1.1/1g/5 h/mg protein) than LDL oxidized 
in the absence of SNAP (6.7/1g/5 h/mg protein). 
3.3. Effect of SNP/light on ABAP-induced oxidation of 
LDL 
To ascertain whether the inhibitory effect of SNP/ 
light is restricted to CuZ+-catalyzed oxidation of LDL, 
ABAP was used as a free radical initiator. Fig. 3 shows 
the effect of SNP/light on the formation of TBARS 
during ABAP-induced oxidation of LDL. Clearly, SNP/ 
light greatly suppressed ABAP-induced LDL oxidation. 
SNP did not affect ABAP-dependent oxidation of LDL 
in the dark (results not shown). It was observed that 
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Fig. 2. Effect of SNAP on Cu2+-catalyzed oxidation of LDL. LDL 
(100/~g/ml) was incubated with Cu 2+ (10/.tM) at 37°C in PBS. (A) 
conjugated iene formation: traces 1 5 contained 0, 0.1, 0.5, 1.0 and 
2.5 mM SNAP, respectively. (B) TBARS formation in the presence (m) 
and absence (D) and of SNAP (1 mM). Data represent means of 
duplicate determinations. 
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Fig. 3. Effect of SNP on ABAP-induced oxidation of LDL. LDL (100 
/~g/ml) was incubated with ABAP (1 raM) in PBS at 37°C in the 
presence (m) and absence ([z) of SNP (100/IM). Samples were contin- 
ually irradiated and aliquots were taken for TBARS analysis. Error 
bars represent mean + S.E.M. (n = 3). 
ABAP oxidation of LDL is accelerated in the presence 
of light, thus preventing direct comparison between re- 
actions performed in the dark. 
3.4. Measurement of'NO formed during SNP/light and 
SNAP decomposition 
"NO released from the decomposition of SNAP and 
SNP/light was measured using the "NO-electrode (Fig. 
4). The initial rate of "NO from SNP (100 ~tM)/light was 
observed to be 760 nM/min. This rate of "NO produc- 
tion completely inhibits LDL oxidation as shown in Fig. 
1. This concentration f SNP continues to generate "NO 
for several hours (Fig. 4A), and inhibition can be sus- 
tained over this time period (Fig. 1). Assuming that the 
decay of SNP is first order and that LDL does not affect 
"NO production, it can be estimated that the rate o f 'NO 
production after 4 h will be 120 nM/min. This rate of 
"NO production is still able to inhibit LDL oxidation 
(Fig. 1). "NO generation from SNAP is spontaneous 
and exhibits markedly different kinetics (Fig. 4B). 
SNAP (40 ~tM) releases all of its "NO within the first 20 
rain; after which time, the "NO concentration decays, 
presumably due to reaction with oxygen. This implies 
that although the absolute amount of "NO released by 
either SNP/light or SNAP may be similar, SNP will 
have a much more pronounced inhibitory effect due to 
the slower release of "NO. This effect is seen in Figs. 1 
and 2. 
The addition of authentic "NO at concentrations (5 
100 /IM) increased the lag-period of Cu2+-catalyzed 
LDL oxidation by approximately 30 min (data not 
shown). This indicates that the effective concentration 
of "NO is the same regardless of the initial concentra- 
tion; presumably, due to the fact that excess "NO is 
rapidly degraded by oxygen. 
172 
Volume 334, number 2 FEBS LETTERS November 1993 
4.00 
- A 
2.00 
0 
z 
0.00 ' I ' I ' I 
0,00 50.00 100.00 150.00 
40.00 - time (min) 
B 
20.00 
0 z 
0.00 ' I ' i , I 
0,00 5.00 10.00 15.00 
time (min) 
Fig. 4. Measurement of "NO released uring SNP/light and SNAP 
decomposition. "NO was monitored using an "NO electrode. Either 
(A) SNP (100/zM) or (B) SNAP (40 pM) was added to PBS in an open 
stirred vessel maintained at37°C. In the case of SNP, the sample was 
continuously illuminated during the course of the experiment. 
4. DISCUSSION 
4.1. Mechanisms of Cue+-catalyzed oxidation of LDL 
The oxidation of LDL by Cu 2+ is thought o occur as 
a result of the decomposition of endogenous LOOH 
associated with LDL as follows [3,25]: 
Cu 2+ + LOOH --~ Cu + + LOO" + H" 
Cu ÷ + LOOH ---) Cu 2÷ + LO ° + OH-  
LO ° + LH --~ L" + LOH 
L ° + 02 --~ LOO ° 
LOO ° + LH --+ LOOH + L ° 
[1] 
[2] 
[31 
[4] 
[5] 
This mechanism involves lipid peroxyl radicals (LOO°), 
lipid alkoxyl radicals (LO °) and lipid radicals (L °) as 
intermediates. The proposed mechanism is autocata- 
lytic, and the time course of oxidation will depend crit- 
ically on the level of endogenous LOOH [25,26]. ' DL 
also contains everal antioxidants, in particular c~-toco- 
pherol, that are able to scavenge LOO °, thus inhibiting 
LDL oxidation [3]: 
LOO" + vit E ~ vit E ° + LOOH 
LOO ° + vit E ° ~ LOO - vit E 
[6] 
[7] 
Figs. 1-3 clearly demonstrate that SNP/light, SNAP, 
and "NO solution can inhibit the progress of both Cu 2+- 
and ABAP-dependent oxidation of LDL. There are at 
least three mechanisms by which "NO can suppre~ 
CuZ+-dependent oxidation of LDL. These are: (i) chela- 
tion of Cu 2+ by "NO to form an inactive complex, (ii) 
removal of LOOH within the LDL particle, and (iii) 
scavenging of L ° and LOO ° by "NO, which will prevent 
both initiation (Reactions 1 and 2) and propagation 
(Reactions 3 and 5). Mechanism (i), namely chelation 
of Cu ~+ by "NO, is unlikely as inhibition occurs when 
ABAP is used as the initiating agent. The kinetics of 
Cu2+-dependent oxidation in the presence of SNAP also 
suggests that Cu 2+ chelation is not the mechanism of 
antioxidant action by °NO. Copper(II) chelators, in 
general, increase the length of the lag-period, but also 
decrease the rate of LDL oxidation during the faster 
propagation phase. This behavior is not observed in 
Fig. 2. Also, ABAP-dependent oxidation, unlike Cu 2+, 
does not depend on the presence of endogenous LOOH. 
We propose, therefore, that "NO generated from the 
decomposition of SNAP and SNP/light inhibits LDL 
oxidation by scavenging L ° and LOO ° formed during 
lipid peroxidation. 
4.2. Reaction between "NO and LDL-lipid derived radi- 
cals 
Much evidence already exists in the literature for the 
facile reaction between itroxides (compounds contain- 
ing >N-O ° groups) and carbon-centered radicals [27- 
32]. Nitroxides have long been used as an antioxidant 
in polymerization reactions [30]. Nitroxides also were 
shown to inhibit lipid peroxidation in microsomes [33]. 
The rate constant for scavenging of the carbon-centered 
radicals by different nitroxides range from 10 l° M -~. s-l-10 s
M -~. s -~. The typical reaction involves the formation of 
alkoxylamines. Nitroxides, however, do not react rap- 
idly with peroxyl radicals [30]. 
In contrast o nitroxides where the electron density is 
distributed on the nitrogen and oxygen atom, the elec- 
tron density distribution in °NO is localized predomi- 
nantly on the nitrogen. As a result, "NO can react with 
carbon-centered, alkoxyl, and peroxyl radicals at a 
rapid rate [27-32]. Thus, the following reactions are 
possible: 
L" + °NO ~ LNO 
L0  ° + °N0 ~- LON0 
L00  ° + "NO ~ LOONO 
[8] 
[9] 
[t0] 
Such radicals are formed during the lipid peroxidation 
process (see Reactions 1-5). "NO is a hydrophobic gas 
and will diffuse into the EDL particle. The local concen- 
trations of both "NO and oxygen will determine whether 
Reaction 8 is able to compete with Reaction 4. 
Reaction o f 'NO with LO ° is unlikely due to both the 
rapid rate of reaction of LO ° with unsaturated fatty acid 
and to the presumably very high local concentration of 
these fatty acids. A more likely reaction of "NO is that 
with LOO ° (Reaction 10) because of their relatively low 
reactivity toward unsaturated lipids. The effect of 
SNAP in increasing the lag-period of LDL oxidation 
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(Fig. 2) is consistent with the hypothesis that "NO is 
acting as a scavenger of  LOO °. Other known LOO" 
scavengers affect the kinetics o f  LDL  oxidat ion identi- 
cally. Character izat ion of  the lipid nitroso products 
(Reactions 8-10) may shed light on the mechanist ic de- 
tails of  the inhibit ion of  LDL  oxidat ion by "NO. 
4.3. Biological implications 
"NO has many propert ies that are believed to be anti- 
atherogenic. These include the inhibit ion of  platelet ag- 
gregation, the inhibit ion of  leukocyte adhesion, and the 
inhibit ion of  vascular smooth muscle prol i ferat ion [34]. 
One of  the early events dur ing hypercholesterolemia is 
a reduction in the abi l i ty of  vessels to respond to endo- 
thel ium-derived relaxing factor (EDRF) ,  now known to 
be "NO. It was observed that oxides of  nitrogen were 
augmented in atherosclerotic tissue [8,35] and recently 
demonstrated that the reduction in EDRF activity is 
due to an increase in superoxide format ion and not a 
decrease in "NO synthesis in the endothel ium [35-37]. 
The reaction between "NO and superoxide has been 
shown to produce -OONO,  a potent oxidant [13]. 
We show here that "NO exhibits potent  ant ioxidant 
activity with respect to LDL  oxidation. It has previ- 
ously been reported that the s imultaneous generation of  
"NO and superoxide as well as -OONO itself, can mod-  
ify LDL  to a potential ly atherogenic form [11,15]. Thus, 
the reaction between "NO and superoxide in the vascu- 
lature, may have the combined effect of  removing an 
ant ioxidant,  namely "NO, generating a pro-oxidant,  
-OONO,  and inhibit ing endothel ia l -dependent relaxa- 
tions. This may enhance the oxidative stress level expe- 
rienced by LDL  within artery wall resulting in modif ica- 
tion of  LDL ,  thereby leading to foam cell formation. 
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